67 results
Page 2 of 4
PRE 14A
xyp2w7
17 Apr 23
Preliminary proxy
4:05pm
424B3
u806b3dd
23 Sep 22
Prospectus supplement
8:19am
424B5
ynnb6vo67j czzwrc
25 Jul 22
Prospectus supplement for primary offering
4:26pm
8-K
EX-10.1
813b8rkb5ocy2eqd4
25 Jul 22
Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering
8:46am
S-3
ergfrdz
1 Jul 22
Shelf registration
8:46am
DEF 14A
tfmsb0vqlrje9
25 Apr 22
Definitive proxy
4:06pm
8-K
EX-99.1
ngj yof17avpzf6
17 Mar 22
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update
7:17am
S-8
vimvobb
16 Mar 22
Registration of securities for employees
4:20pm
10-K
e5opd7c420jvaa
16 Mar 22
Annual report
4:05pm
10-Q
6msc5 b8q72dtwsr
13 Aug 21
Quarterly report
4:06pm
S-8
EX-99.2
mjexpkg 7sv
19 Jul 21
Registration of securities for employees
5:27pm
S-8
EX-99.3
rwrsiqois6ge36zwy
19 Jul 21
Registration of securities for employees
5:27pm
S-8
xkgrp3k
19 Jul 21
Registration of securities for employees
5:27pm